SHIELDNCT06176625
Sight and Hearing Investigation Into Effects on Delirium
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
Notable Results posted: Nov 18, 2026 Show 8 more changesShow less
- Eligibility criteria expanded, about 6 words
- Primary endpoints revised (2)
- Enrollment target: 1543 to 1312
- Interventions: Amplifier Use (Behavioral), Communication Signage (Behavioral) to not stated
- Secondary endpoints revised (3)
- Study description shortened, about 76 words
- Publications: details revised at 27 of 27 entries
- Study arms: 4 to 1
- Notable Phase: Not applicable to Not specifiedv4
- Minor Trial status: Active, Not Recruiting to Completed
- Enrollment target: estimated 1500 to confirmed 1543
- Study completion date changed from estimate of Aug 31, 2024 to Dec 15, 2023
- Minor Trial status: Recruiting to Active, Not Recruiting
- Interventions: Communication Signage & Amplifier Use (Behavioral), Communication Signage (Behavioral) to Amplifier Use (Behavioral), Communication Signage (Behavioral)
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Number of Participants With Delirium as Assessed by 4AT Rapid Clinical Test for Delirium (4AT)
Timeframe: Approximately daily during hospitalization up to 6 months
Percentage of Participants With Delirium as Assessed by 4AT Rapid Clinical Test for Delirium in Proportion to Total Number of Patients Screened
Timeframe: Approximately daily during hospitalization up to 6 months
Secondary (3)
Severity of Delirium Quantified by the 3-Minute Diagnostic Interview for Confusion Assessment Method-Defined Delirium (3D-CAM)
Satisfaction With Care Assessed Using the Questionnaire on the Quality of Physician-Patient Interaction (QQPI)
Satisfaction With Care Assessed Using the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS)
Arms and interventions
Delirium & Sensory Loss
The observational portion of the study, during which participants are screened for delirium. Consented individuals also complete bedside hearing and vision screenings, and provide information regarding care on patient satisfaction questionnaires.
Sites
1 site in 1 country
- Johns Hopkins Bayview Medical CenterBaltimore, Maryland, United States